Messenger RNA vaccines after surgery for pancreatic cancer
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests messenger RNA (mRNA) vaccines, given alone or with other treatments, after surgery for pancreatic cancer. The goal is to see if the vaccines can help prevent the cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had surgery to remove your pancreatic cancer, and the surgeon removed all visible tumor (even if some cancer cells were left at the edges).
- Your cancer has not spread to distant organs (like the liver or lungs).
- You are in generally good health, able to do your daily activities, and expected to live at least 6 months.
- You have recovered from surgery and any complications.
- You have not had any prior treatment for pancreatic cancer (like chemotherapy or radiation) except the surgery.
- You are willing to use effective birth control if you are able to have children.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized mRNA vaccine combined with an immunotherapy drug (PD-1 inhibitor) to prevent pancreatic cancer from returning after surgery. It is for patients whose tumors have specific genetic features and who cannot have standard chemotherapy.
This study tests a personalized vaccine made from your own tumor, combined with a drug that helps your immune system fight cancer cells. The goal is to see if this approach can help prevent your pancreatic cancer from coming back after surgery.
This trial tests a personalized vaccine made from your own tumor's genetic information. The vaccine is given after surgery to try to train your immune system to fight any remaining cancer cells and reduce the chance of the cancer coming back.
This study tests a personalized vaccine made from your tumor's unique markers. It aims to help your immune system attack pancreatic cancer that has spread or returned.
This trial tests a new tumor vaccine combined with standard chemotherapy for people with pancreatic cancer that has spread. The vaccine aims to help your immune system fight the cancer, and the chemo helps shrink tumors.
This trial tests a personalized mRNA vaccine (made from your tumor's unique markers) combined with standard chemotherapy after surgery for pancreatic cancer. The goal is to see if the vaccine can help prevent the cancer from coming back.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.